PPARβ/δ in human cancer

Biochimie. 2017 May:136:90-99. doi: 10.1016/j.biochi.2016.10.019. Epub 2016 Dec 2.

Abstract

The nuclear receptor factor peroxisome proliferator-activated receptor (PPARβ/δ) can regulate its target genes by transcriptional activation or repression through both ligand-dependent and independent mechanism as well as by interactions with other transcription factors. PPARβ/δ exerts essential regulatory functions in intermediary metabolism that have been elucidated in detail, but clearly also plays a role in inflammation, differentiation, apoptosis and other cancer-associated processes, which is, however, mechanistically only partly understood. Consistent with these functions clinical associations link the expression of PPARβ/δ and its target genes to an unfavorable outcome of several human cancers. However, the available data do not yield a clear picture of PPARβ/δ's role in cancer-associated processes and are in fact partly controversial. This article provides an overview of this research area and discusses the role of PPARβ/δ in cancer in light of the complex mechanisms of its transcriptional regulation and its potential as a druggable anti-cancer target.

Keywords: Breast cancer; Lung cancer; Ovarian cancer; Peroxisome proliferator-activated receptor β/δ; Transcriptional regulation.

Publication types

  • Review

MeSH terms

  • Angiopoietins / genetics
  • Gene Expression Regulation / physiology
  • Humans
  • Ligands
  • Neoplasms / genetics
  • Neoplasms / physiopathology*
  • PPAR delta / genetics
  • PPAR delta / physiology*
  • PPAR-beta / genetics
  • PPAR-beta / physiology*
  • Protein Serine-Threonine Kinases / genetics
  • Pyruvate Dehydrogenase Acetyl-Transferring Kinase
  • RNA, Small Interfering / genetics
  • Transcription, Genetic / physiology

Substances

  • Angiopoietins
  • Ligands
  • PPAR delta
  • PPAR-beta
  • Pyruvate Dehydrogenase Acetyl-Transferring Kinase
  • RNA, Small Interfering
  • angiopoietin 4
  • Protein Serine-Threonine Kinases